You are viewing: South Korea Compounding Pharmacy Market analysis
Part of: Compounding Pharmacy Market (Global)

The South Korea Compounding Pharmacy Market was valued at $84.3 Million in 2025 and projected to reach to $113.3 Million by 2030, representing a compound annual growth rate of 6.1%. South Korea's compounding pharmacy market is poised for sustained expansion through 2030, driven by an aging population, rising healthcare expenditure, and growing acceptance of personalized medicine among both healthcare providers and patients.

South Korea Compounding Pharmacy Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Compounding Pharmacy Market Trends and Insights

  • This growth trajectory reflects South Korea's advancing healthcare infrastructure and increasing demand for personalized pharmaceutical solutions.
  • South Korea's compounding pharmacy sector benefits from rising patient preference for customized medications and the country's strong regulatory framework supporting pharmaceutical innovation. The South Korea compounding pharmacy market is driven by demographic shifts, including an aging population requiring specialized medication formulations.
  • South Korea's healthcare system increasingly recognizes the value of compounded medications for patients with allergies, sensitivities, or unique dosage requirements.
  • Between 2025 and 2030, South Korea is expected to see expanded adoption of compounding services across hospitals, clinics, and retail pharmacies, supported by growing healthcare expenditure and technological advancement in pharmaceutical compounding..

Key Market Statistics

  • CAGR (2025-2030) 6.1% CAGR
  • Market Size, 2025 ~USD 84.3 Million
  • Forecast, 2030 ~USD 113.3 Million
  • Country South Korea

South Korea Compounding Pharmacy Market Overview

Market Valuation & Growth :

South Korea's compounding pharmacy market is valued at USD 84.3 million in 2025, with projected growth to USD 113.3 million by 2030, representing a robust 6.1% CAGR, outpacing the global average of 5.7%.

Healthcare Infrastructure Advancement :

South Korea's sophisticated healthcare system and high digital adoption rates are driving demand for personalized pharmaceutical solutions, positioning the country as a key growth market in Asia-Pacific.

Personalized Medicine Demand :

Increasing consumer preference for customized medications tailored to individual patient needs is accelerating compounding pharmacy adoption across South Korea's urban and suburban healthcare networks.

Regulatory Environment :

South Korea's stringent pharmaceutical regulations and quality standards create barriers to entry, benefiting established compounding pharmacies and creating opportunities for compliant market entrants.

South Korea Compounding Pharmacy Market Dynamics

  • The country's advanced pharmaceutical infrastructure and strong regulatory framework support market professionalization and quality assurance.
  • Technological integration, including automation and digital prescription systems, will enhance operational efficiency and patient accessibility.
  • Additionally, increasing collaboration between compounding pharmacies and hospitals, coupled with expanding insurance coverage for customized medications, will further accelerate market penetration across South Korea's healthcare ecosystem..

Market Ecosystem

logo-mobile

COMPOUNDING PHARMACY MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Provides sterile and non-sterile compounding services, including ready-to-dispense and ready-to-administer personalized medicines for pharmacies, hospitals, and clinics | Its compounding operations support customized strengths, dosage forms, ingredient requirements, and therapies where commercially available medicines may be unsuitable or unavailable. Enables healthcare providers to address patient-specific medication requirements, drug shortages, discontinued products, allergies, and dosage-form limitations while outsourcing complex sterile and non-sterile compounding activities.
company logo
Operates both a 503A compounding pharmacy for patient-specific prescriptions and an FDA-registered 503B outsourcing facility for office-use medications | Its portfolio includes compounded preparations across multiple therapeutic areas and dosage forms, supported by sterile batch testing and cGMP processes at the 503B facility. Expands access to individualized medicines and multiple strengths and dosage forms while enabling healthcare providers to procure larger-scale compounded products from a regulated outsourcing facility.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • South Korea's compounding pharmacy market is valued at USD 84.3 million in 2025 with a projected CAGR of 6.1% through 2030.
    • South Korea's aging population and rising demand for personalized medications are primary growth drivers for the compounding pharmacy sector.
    • South Korea's strong regulatory environment and advanced healthcare infrastructure support market expansion and service adoption.
    • South Korea is expected to reach USD 113.3 million in market size by 2030, driven by increased hospital and retail pharmacy integration.

    Compounding Pharmacy Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment HORMONE REPLACEMENT THERAPIES (Therapeutic Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.7% from 2025 to 2030
    Largest Segment PHARMACEUTICAL DOSAGE ALTERATION (Compounding Type)
    Market Size Base Year (Billions) ~USD 14.71 (2025)
    Revenue Forecast (Billions) ~USD 19.41 (2030)
    Segments Covered Product, Compounding Type, Therapeutic Application

    South Korea Compounding Pharmacy Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Nasal Drugs
    • Ophthalmic Drugs
    • Oral Drugs
    • Other Products
    • Parenteral Drugs
    • Rectal Drugs
    • Topical Drugs

    By Compounding Type

    • Currently Unavailable Pharmaceutical Manufacturing
    • Pharmaceutical Dosage Alteration
    • Pharmaceutical Ingredient Alteration

    By Therapeutic Application

    • Dermal Disorders
    • Hormone Replacement Therapies
    • Nutritional Supplements
    • Other Therapeutic Applications
    • Pain Management

    Target Audience

    • Pharmaceutical Companies : Evaluate market entry opportunities and expansion strategies in South Korea's growing compounding pharmacy sector to diversify revenue streams and capture personalized medicine demand.
    • Healthcare Investors & PE Firms : Assess investment potential and ROI projections for compounding pharmacy businesses in South Korea's high-growth market with favorable regulatory and demographic tailwinds.
    • Pharmacy Operators & Chains : Understand South Korea's market dynamics, competitive positioning, and growth opportunities to optimize service offerings and expand compounding pharmacy capabilities.
    • Healthcare Consultants & Advisors : Provide clients with South Korea-specific market intelligence, competitive benchmarking, and strategic recommendations for healthcare and pharmaceutical sector initiatives.
    • Government & Policy Makers : Utilize market data to inform healthcare policy, pharmaceutical regulations, and healthcare infrastructure development strategies aligned with South Korea's personalized medicine growth trajectory.

    Key Companies in the South Korea Compounding Pharmacy Market

    CompanyHQOwnershipStrongest segments
    BAXTERUnited StatesPublic CompanyMedical Products & Therapies (IV, infusion, parenteral nutrition, renal-related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),
    FAGRONBelgiumPublic CompanyEssentials (APIs, excipients, bases),Brands (derma, immunology, hair, scar care),Compounding Services,

    BAXTER

    Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates as a major medical device and pharmaceutical manufacturer serving global markets.

    FAGRON

    Fagron is a publicly traded Belgian pharmaceutical company founded in 1990 with 4,880 employees. The company focuses on pharmaceutical compounding and specialty pharmacy solutions.

    Reasons to Buy this Report

    • Market-Specific Growth Insights : Gain detailed understanding of South Korea's 6.1% CAGR trajectory and identify high-growth segments within the country's compounding pharmacy sector through comprehensive market analysis and forecasting.
    • Competitive Landscape Intelligence : Access in-depth competitive analysis specific to South Korea's market players, regulatory requirements, and market entry strategies to inform strategic business decisions and positioning.
    • Investment & Expansion Planning : Leverage South Korea-specific market sizing and projections to evaluate investment opportunities, expansion feasibility, and revenue potential in this high-growth Asian healthcare market.
    • Regulatory & Compliance Framework : Understand South Korea's unique pharmaceutical regulations, quality standards, and compliance requirements essential for successful market entry and operational sustainability.
    • Customer Demand Analysis : Identify South Korea-specific patient demographics, healthcare provider preferences, and emerging demand drivers to tailor product offerings and marketing strategies effectively.

    Frequently asked questions

    What is the current market size of the compounding pharmacy sector in South Korea?

    South Korea's compounding pharmacy market is valued at USD 84.3 million in 2025.

    What is the projected market size for South Korea's compounding pharmacy market by 2030?

    South Korea's compounding pharmacy market is projected to reach USD 113.3 million by 2030.

    What is the CAGR for South Korea's compounding pharmacy market?

    South Korea's compounding pharmacy market is expected to grow at a CAGR of 6.1% from 2025 to 2030.

    What factors are driving growth in South Korea's compounding pharmacy market?

    South Korea's market growth is driven by an aging population, increased demand for personalized medications, strong regulatory support, and expanding healthcare infrastructure.

    How does South Korea's compounding pharmacy market compare to other Asia Pacific countries?

    South Korea's 6.1% CAGR demonstrates robust growth within the Asia Pacific region, supported by advanced healthcare systems and high pharmaceutical spending.

    RESEARCH METHODOLOGY

    This study involved four major activities to estimate the current size of the compounding pharmacy market. We conducted exhaustive secondary research to gather information on the market, its peer markets, and its parent market. The team then validated these findings, assumptions, and sizing with industry experts across the value chain through primary research. We used both top-down and bottom-up approaches to estimate total market size. We then used data triangulation to estimate market size by segment and subsegment.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the compounding pharmacy market. The secondary sources used for this study include US Food and Drug Administration (FDA), American Pharmacists Association (APhA), International Academy of Compounding Pharmacists (IACP), National Community Pharmacists Association (NCPA), Parenteral Drug Association (PDA), American Society of Health-System Pharmacists (ASHP), Pharmacy Compounding Accreditation Board (PCAB), European Directorate for the Quality of Medicines & HealthCare (EDQM), European Medicines Agency (EMA), International Pharmaceutical Federation (FIP), Journal of Compounding & Specialty Pharmacy (JCSP), National Center for Biotechnology Information (NCBI), Pharmaceutical Research and Manufacturers of America (PhRMA), Pharma & Biopharma Outsourcing Association (PBOA), and World Journal of Pharmaceutical Research (WJPR). Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information on major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    We conducted in-depth interviews with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. We interviewed primary sources from both the supply and demand sides of the market to gather qualitative and quantitative data. The following is a breakdown of the primary respondents:

    Compounding Pharmacy Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    We estimated the global size of the compounding pharmacy market using multiple approaches. We used a detailed market estimation approach to estimate and validate the market value and other dependent submarkets. We also used these methods extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following.

    Compounding Pharmacy Market: Top-Down and Bottom-Up Approach

    Compounding Pharmacy Market Top Down and Bottom Up Approach

    Data Triangulation

    After estimating the market size using the process described above, we divided the total market into several segments and subsegments. To complete the overall market analysis and obtain precise statistics for all segments and subsegments, we used data triangulation and market breakdown methods where applicable. We triangulated the data by examining factors and trends from both the demand and supply sides.

    Market Definition

    A compounding pharmacy is a specialized practice in which a licensed pharmacist combines, mixes, or alters raw drug ingredients to formulate customized medications tailored to individual patients' unique health needs. This process allows pharmacists to create pharmaceutical products in various forms, such as liquids, creams, gels, or capsules, and can be vital for patients with specific allergies, intolerances, or those needing dosages not commercially available. Compounding pharmacists often work closely with healthcare providers to develop formulas that address particular medical conditions, ensuring that each preparation is safe, effective, and personalized to optimize patient care. Additionally, compounding pharmacies adhere to stringent regulatory standards to maintain the integrity and quality of the medications they produce.

    Key Stakeholders

    • Pharmaceutical & Biotechnology Companies
    • Compounding Pharmacies
    • Research & Consulting Firms
    • Academic Medical Centers
    • Government Regulatory & Research Organizations
    • Quality Assurance & Accreditation Bodies
    • Clinical Research Institutes

    Report Objectives

    • To define, describe, and forecast the compounding pharmacy market based on product, compounding type, therapeutic application, sterility, end user, and region
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall compounding pharmacy market
    • To analyze opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to five regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Africa)
    • To profile the key players and analyze their market share and core competencies
    • To analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

    Available customizations:

    With the given market data, MarketsandMarkets offers customization as per the company’s specific needs. The following options are available for the report:

    Geographical Analysis

    • A further breakdown of the Rest of Asia Pacific compounding pharmacy market into countries
    • A further breakdown of the Rest of Europe compounding pharmacy market into countries
    • A further breakdown of the Rest of Latin America compounding pharmacy market into countries

    Company Information

    • Detailed analysis and profiling of additional market players (up to five).
     

     

    Get the Full Compounding Pharmacy Market Report

    Full forecast, segment splits, and company analysis for all Compounding Pharmacy Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status